8 min

Clot risks: The Pill versus the vaccine More or Less: Behind the Stats

    • Business

The Astra Zeneca Covid 19 jab remains in the headlines because some regulators have concluded that it may raise the risk of a very rare type of blood clot, albeit to a risk that is still very low. In the past few weeks a number of countries have said they will limit its use to older age groups. But people are drawing comparisons to the contraceptive pill which is well-known to increase the risk of clots and asking why this level of risk is tolerated. Is this comparison fair?

Tim Harford speaks to Professor Frits Rosendaal from the University of Leiden in the Netherlands and Susan Ellenberg, professor of biostatistics at the University of Pennsylvania.

The Astra Zeneca Covid 19 jab remains in the headlines because some regulators have concluded that it may raise the risk of a very rare type of blood clot, albeit to a risk that is still very low. In the past few weeks a number of countries have said they will limit its use to older age groups. But people are drawing comparisons to the contraceptive pill which is well-known to increase the risk of clots and asking why this level of risk is tolerated. Is this comparison fair?

Tim Harford speaks to Professor Frits Rosendaal from the University of Leiden in the Netherlands and Susan Ellenberg, professor of biostatistics at the University of Pennsylvania.

8 min

Top Podcasts In Business

In Good Company with Nicolai Tangen
Norges Bank Investment Management
Take a moment with Holzweiler
Holzweiler
The Diary Of A CEO with Steven Bartlett
DOAC
Pengesnakk
Moderne Media
Økonominyhetene
Finansavisen
Dine Penger - Pengerådet
Dine Penger

More by BBC

Global News Podcast
BBC World Service
The Lazarus Heist
BBC World Service
Just One Thing - with Michael Mosley
BBC Radio 4
In Our Time: Philosophy
BBC Radio 4
In Our Time
BBC Radio 4
The Documentary Podcast
BBC World Service